We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Btg Plc | LSE:BTG | London | Ordinary Share | GB0001001592 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 840.00 | 839.00 | 840.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
12/9/2017 16:13 | flatline . whens the big news due on codes ? | bargainbob | |
11/9/2017 17:06 | i hate hedge fund managers it ought to be a proscribed job punishable by a minimum of 5 yrs and, yes, i manage my own money | adejuk | |
11/9/2017 15:39 | it's never been good at flatlining - pun and true like a heart failure patient read out | adejuk | |
11/9/2017 15:38 | be nice to flatline here and become strong support | adejuk | |
11/9/2017 08:10 | Holding £7 for the opening . | bargainbob | |
08/9/2017 16:05 | On the wings of love | bargainbob | |
08/9/2017 15:11 | 8 next stop | adejuk | |
08/9/2017 14:00 | for a little while wait till next year - i'll be saying that about 10 | adejuk | |
01/9/2017 15:54 | Good that Louise is exercising her share options and increasing her holding. | fhmktg | |
31/8/2017 18:20 | Expecting a blow out here . | bargainbob | |
31/8/2017 18:19 | Good run...for these small mercies we give thanks! | fhmktg | |
31/8/2017 15:21 | well, i did drink the blood my zombie friends [mostly financial analysts] tell me that is what makes the difference ! | adejuk | |
31/8/2017 15:17 | That's a terrible thing to do to AQR's head hen: now headless. Will that betoken any change, though? They keep on running (things) around for a long time afterwards, don't they? | muffmitz | |
31/8/2017 14:54 | i have just be-headed a chicken | adejuk | |
31/8/2017 11:04 | I think some incantations, invocations or even imprecations would be in order. That might just crack it. For those deluded shorters an exorcism would be just too kind. | muffmitz | |
31/8/2017 10:12 | Seven pounds , will it hold Captain . | bargainbob | |
30/8/2017 12:44 | it could just be pound , dollar re-rating . | bargainbob | |
30/8/2017 09:42 | Mid November for the interims.....perhaps a confirmation that coding for Varithena WILL come from Jan 1st?That would underpin the share price for continued move North.Last year's hedging for the dollar will be out of the way as well. | fhmktg | |
30/8/2017 08:41 | Could it be that we shall soon be hearing a gratifying cracking noise followed by the thunder of feet as the Masters of the Universe rush towards the door? I cannot for the life of me work out what financial benefit those paragons at AQR have gained from their long-standing short position in BTG. One thing for certain is that it's not normally a linear rise although the recent up movement has been very pretty. | muffmitz | |
29/8/2017 18:54 | Oh nice drip increase going on. | bargainbob | |
24/8/2017 21:59 | Woodford Patient Capital Trust is a closed end investment trust structure and sales and purchases of the shares by investors increase or decrease the value of the shares and only affect the discount or premium to the underlying NAV. Sales of shares by investors does not mean that underlying investments have to be sold to meet redemptions. | pj84 | |
24/8/2017 20:55 | From Dave on 3eye It appears BTG have given the The Society of Interventional Oncology (SIO) a grant to nurture and support interventional oncology worldwide, BTG plc announce recently their 2017 Interventional Oncology / Immuno-Oncology research grant recipients. The investigators and project proposals that have been awarded grants are www.prnewswire.co.uk Rafael Duran, MD Centre Hospitalier Universitaire Vaudois Investigating the Immunobiology of Hepatocellular Carcinoma in Patients Undergoing Y90 Radioembolization Joseph P. Erinjeri, MD, PhD Memorial Sloan Kettering Cancer Center T-Cell Clonality and Cancer Neoantigen Presentation Following Interventional Oncology (IO) Therapies: Which IO Techniques Optimally Stimulate the Immune System? Florian J. Fintelmann, MD Massachusetts General Hospital A Pilot Study of Cryoablation Combined with Immune Checkpoint Inhibitor Therapy in Patients with PD-1 Refractory Metastatic Melanoma: Prospective Clinical Research and Correlative Laboratory Studies Stephen Hunt, MD, PhD University of Pennsylvania TAEVax: Immunobiologic Treatment Effects of Embolization in a Rat HCC Model "We are very pleased that through the generosity of BTG, SIO has been able to fund the most meritorious, cutting-edge research that combines the strengths of interventional oncology and immuno-oncology-two disciplines that hold great promise for improving cancer therapy. The large number of high quality submissions to this grant call attests to the intense interest of interventional oncologists worldwide. for more info go to www.prnewswire.co.uk BE HAPPY Dave | bargainbob |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions